As the President of ThinkGenetic, I am responsible for ensuring the company makes steady progress toward our goals. I provide regular feedback on this progress to our board members, investors,… CONTINUE
Stealth BioTherapeutics Supports Addition of Mitochondrial Genetic Diseases in ThinkGenetic Knowledge Base
In a public press release this week, ThinkGenetic announced that Stealth BioTherapeutics (Stealth) has funded content design, content creation, and clinical trials advertising for mitochondrial diseases. As a first step… CONTINUE
Fabry Disease Study Using ThinkGenetic Diagnostic Aid to be Showcased at WORLDSymposium
ThinkGenetic SymptomMatcherTM Diagnostic Aid Tested for Patients with Fabry Disease in Study by Emory University School of Medicine, Grady Memorial Hospital and University of Georgia College of Pharmacy ThinkGenetic today… CONTINUE
Connecting, Collaborating, and Activating at the Vibrant 2017 RARE Patient Advocacy Summit
While many of our ThinkGenetic teammates helped others “harness their inner power” at the National Society of Genetic Counselors Annual Conference in Columbus, Ohio, ThinkGenetic CEO, Dave Jacob and I… CONTINUE
Harnessing the Power Within at the 2017 National Society of Genetic Counselors Annual Conference
Have you ever been able to achieve something you never thought possible, yet when you look back you realize that you always had the power to do it? Maybe someone… CONTINUE